• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee.

作者信息

Virani Salim S, Morris Pamela B, Agarwala Anandita, Ballantyne Christie M, Birtcher Kim K, Kris-Etherton Penny M, Ladden-Stirling Amanda B, Miller Michael, Orringer Carl E, Stone Neil J

出版信息

J Am Coll Cardiol. 2021 Aug 31;78(9):960-993. doi: 10.1016/j.jacc.2021.06.011. Epub 2021 Jul 28.

DOI:10.1016/j.jacc.2021.06.011
PMID:34332805
Abstract
摘要

相似文献

1
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee.2021年美国心脏病学会（ACC）关于持续性高甘油三酯血症患者降低动脉粥样硬化性心血管疾病（ASCVD）风险管理的专家共识决策路径：美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2021 Aug 31;78(9):960-993. doi: 10.1016/j.jacc.2021.06.011. Epub 2021 Jul 28.
2
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.2017 年对 2016 年美国心脏病学会专家共识决策途径的重点更新：非他汀类药物在降低动脉粥样硬化性心血管疾病风险管理中的作用：美国心脏病学会专家组的专家共识决策途径报告。
J Am Coll Cardiol. 2017 Oct 3;70(14):1785-1822. doi: 10.1016/j.jacc.2017.07.745. Epub 2017 Sep 5.
3
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee.2022年美国心脏病学会解决方案集监督委员会关于非他汀类疗法在降低低密度脂蛋白胆固醇以管理动脉粥样硬化性心血管疾病风险中的作用的专家共识决策路径报告。
J Am Coll Cardiol. 2022 Oct 4;80(14):1366-1418. doi: 10.1016/j.jacc.2022.07.006. Epub 2022 Aug 25.
4
2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee.2019年美国心脏病学会解决方案集监督委员会关于心力衰竭住院患者风险评估、管理及临床进程的专家共识决策路径报告
J Am Coll Cardiol. 2019 Oct 15;74(15):1966-2011. doi: 10.1016/j.jacc.2019.08.001. Epub 2019 Sep 13.
5
Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).根据美国心脏病学会/美国心脏协会胆固醇管理指南，在他汀类药物候选者中进行冠状动脉钙测试的意义：MESA（动脉粥样硬化多民族研究）。
J Am Coll Cardiol. 2015 Oct 13;66(15):1657-68. doi: 10.1016/j.jacc.2015.07.066.
6
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.2016年美国心脏病学会临床专家共识文件特别工作组报告：非他汀类疗法在降低低密度脂蛋白胆固醇以管理动脉粥样硬化性心血管疾病风险中的作用专家共识决策路径
J Am Coll Cardiol. 2016 Jul 5;68(1):92-125. doi: 10.1016/j.jacc.2016.03.519. Epub 2016 Apr 1.
7
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018 年美国心脏协会/美国心脏病学会/美国心血管血管外科学会/美国医师协会/美国心脏病学学院/美国糖尿病协会/美国老年学会/美国药学会/美国物理治疗协会/北美介入放射学会/国家脂质协会/美国预防、检测、评估与治疗高血压全国联合委员会临床实践指南：管理血胆固醇的系统评价。
J Am Coll Cardiol. 2019 Jun 25;73(24):3210-3227. doi: 10.1016/j.jacc.2018.11.004. Epub 2018 Nov 10.
8
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk.国家脂质协会关于在他汀类药物治疗的甘油三酯升高和高或极高 ASCVD 风险患者中使用二十碳五烯酸乙酯的科学声明。
J Clin Lipidol. 2019 Nov-Dec;13(6):860-872. doi: 10.1016/j.jacl.2019.10.014. Epub 2019 Nov 2.
9
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.2020年2型糖尿病患者降低心血管风险新型疗法专家共识决策路径：美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2020 Sep 1;76(9):1117-1145. doi: 10.1016/j.jacc.2020.05.037. Epub 2020 Aug 5.
10
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.

引用本文的文献

1
Demystifying the nuances of the lipid patient: a guide for primary care providers.揭开血脂异常患者的细微差别：初级保健提供者指南
Am J Prev Cardiol. 2025 Jul 26;23:101070. doi: 10.1016/j.ajpc.2025.101070. eCollection 2025 Sep.
2
The impact of olezarsen on hypertriglyceridemia in high cardiovascular risk patients: a systematic review, meta-analysis, and meta-regression.奥来扎生对心血管高危患者高甘油三酯血症的影响：一项系统评价、荟萃分析和荟萃回归分析
Ann Med Surg (Lond). 2025 Jun 23;87(8):5173-5184. doi: 10.1097/MS9.0000000000003505. eCollection 2025 Aug.
3
Application of the Weibull Model to Statins for Triglyceride Management in Patients With Hyperlipidaemia.
威布尔模型在高脂血症患者甘油三酯管理中应用于他汀类药物的研究
Pharmacol Res Perspect. 2025 Aug;13(4):e70159. doi: 10.1002/prp2.70159.
4
Exploratory study on the association of fish consumption with serum cotinine levels in the general adult population.一般成年人群中鱼类消费与血清可替宁水平关联的探索性研究。
BMC Nutr. 2025 Aug 4;11(1):158. doi: 10.1186/s40795-025-01139-6.
5
Rates of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemia in US clinical practice.美国临床实践中重度或极重度高甘油三酯血症成人患者的急性胰腺炎和心血管事件发生率。
Lipids Health Dis. 2025 Jul 28;24(1):252. doi: 10.1186/s12944-025-02658-8.
6
Using the Avocado as an Evening Snack to Investigate Whole Food Matrix and Macronutrient Composition on Morning Metabolic Indices in Adults With Prediabetes.以牛油果作为晚间零食，研究全食物基质和常量营养素组成对成人糖尿病前期患者早晨代谢指标的影响。
Curr Dev Nutr. 2025 Jun 12;9(7):107486. doi: 10.1016/j.cdnut.2025.107486. eCollection 2025 Jul.
7
Targeting Triglycerides: The Rise of Apolipoprotein C3 and Angiopoietin-Like Protein 3 Inhibitors.靶向甘油三酯：载脂蛋白C3和血管生成素样蛋白3抑制剂的兴起
Am J Cardiovasc Drugs. 2025 Jul 12. doi: 10.1007/s40256-025-00748-7.
8
A Critical Appraisal of Lipid Management in the Post-Statin Era: Comparison on Guidelines, Therapeutic Targets, and Screening in a Case-Based Framework of Lipid Management.他汀类药物时代后脂质管理的批判性评估：基于病例的脂质管理框架中指南、治疗靶点及筛查的比较
JACC Adv. 2025 Jun;4(6 Pt 2):101823. doi: 10.1016/j.jacadv.2025.101823.
9
SHR-1918, A Monoclonal Antibody Against Angiopoietin-Like 3, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Study.SHR-1918（一种抗血管生成素样蛋白3单克隆抗体）在健康受试者中的随机、双盲、安慰剂对照研究。
Clin Pharmacokinet. 2025 Jun 27. doi: 10.1007/s40262-025-01539-8.
10
Lipid-Lowering RNA Therapeutics for Atherosclerotic Cardiovascular Disease Prevention: A State-of-the-Art Review.用于预防动脉粥样硬化性心血管疾病的降脂RNA疗法：最新综述
BioDrugs. 2025 Jun 25. doi: 10.1007/s40259-025-00731-3.